“Medicinal Healing Booth System”

IPApproach LLC is pleased to present the exclusive patents for licencing or sale Medicinal Healing Booth Systemwhich includes U.S. Granted Patents US 9,440,041 B1 assigned to Marissa R. LacayoThe IP relates to a system, for treating a user with medicated vapor or steam, inside a self-contained booth that is computer-operated and self-timed with various safety features to treat upper respiratory ailments. This  healing booth comprises with steam generation system, temperature regulation system, sterilization system and microprocessor based control system to implement all the processes automatically.

The technology disclosed provides the following  advantages:

  • A medicinal healing booth system for treating a user with medicated steam for helping to relieve symptoms of colds, allergies, and asthma.
  • This system provides a quick, easy way to dispense medication, such as herbal antibiotics through a vapor or steam.
  • This system is a self-contained system which requires limited supervision.
  • The infrared radiated heat, at a precised temperature and the patient ’s body heat (sweating), acts together safely to eliminate the cold virus.
  • It self-cleans after every use with an Ultraviolet (UV) automatic system.
  • It frees doctor ’s agendas a lot quicker from having to see patients with reoccurring symptoms.

Please contact Justin Ehrlickman via email at justin@ipapproach.com or phone at 845-558-7901 to receive a Brokerage Marketing Package.

abstract-3166168__340

“System to Monitor Dynamic Movement of Objects”

Exclusively offered for sale or license by IPApproach, LLC, a leading patent brokerage firm.

Any questions about this patent portfolio sale offering should be directed to:

Justin Ehrlickman | justin@ipapproach.com | 845-558-7901

               

Details of the offering and planned bidding process for purchasing the patent portfolio is outlined below:

THIS OFFERING IS FOR SALE  AND LICENSE

  • FOR SALE:  5 GROUPS  –  6 US ISSUED PATENTS  &  9 US APPLICATIONS
  • CORE PATENTS FOR LICENSING:  5  US ISSUED PATENTS & 1 US APPLICATION

IP Approach is pleased to present the exclusive patents for the sale or license in following technology categories:

  1. System to monitor objects: 3 Issued, 5 Applications
    • US 10,724,846 B2; US 10,856,739 B2; US 10,861,171 B2; US 20190063898 A1; US 20190274560 A1; US 20190274602 A1; US 20190385281 A1; US 20200103217 A1; US 20190374113 A1
  2. Authentication: 1 Issued
    • US 9,916,433 B2
  3. Medical Parameter: 1 Issued,1 Application
    • US 20190159701 A1; US 10,750,956 B2
  4. Medical Parameter - Glucose: 1 Issued,1 Application
    • US 10,595,755 B2; US 20200232915 A1
  5. Cell Viability Assessment: 1 Application
    • US 20200160523 A1
  6. CORE Available for Licensing : 5 Issued,1 Application
    • US 8,638,991 B2; US 9,668,672 B2; US 10,390,729 B2; US 20190374132 A1; US 9,636,041 B2; US 10,398,314 B2
abstract-3166168__340

"CHELATE COMPOUNDS"

IPApproach LLC is pleased to present the exclusive patent for sale “CHELATE COMPOUNDS” which include U.S. Patent US 8,288,587 B2 assigned to Mohammad Hassan Nazaran. The IP relates to a chelate compound which comprises of nitrogen source, an acidic source, first element source including sodium, chlorine, potassium and second element source including Ca, Mg, Br, Cl.

The technology disclosed provides the following advantages,

  • The chelate compounds, such as chelate nanocompounds, improves the delivery and collection of various elements and/or metal ions in all pH environments, including highly acidic and alkaline environments.
  • The small size of chelate nanocompounds less than 100 nm in at least one dimension, increases the likelihood of cell wall penetration.
  • The chelate nanocompunds has higher resistance against structural breakage and/or deformation in highly acidic or alkaline environments.
  • The high customizability of the chelate nanocompounds to deliver or collect different elements and/or metal ions enables the chelate nanocompounds to be optimized for various uses.
  • The chelate nanocompounds can be used in various environments, such as, for example, farms, orchards, treatment facilities, factories, research centers, plants, animals, and/or humans.
  • The chelate compounds can reduce spoiled crop, improve soil texture, reduce underground water pollution, and increase the metabolism in plants resulting in more efficient absorption of elements in the soil and other fertilizers.

Please contact Justin Ehrlickman via email at justin@ipapproach.com or phone at 845-558-7901 to receive a Brokerage Marketing Package.

abstract-3166168__340

“Walker Adapter”

IPApproach LLC is pleased to present the exclusive patents for sale “Walker adapter” which includes U.S. Granted Patent US 8,544,486 B1 assigned to Se Sunrise Holdings LLC. The IP includes an adapter for use with a walker.

The technology disclosed provides the following  advantages:

    • The adapter has a mesh that includes a running surface for engaging soft surfaces such as sand, dirt, and the like, into which conventional walker legs generally sink.
    • Member used in the adapter is constructed from any material (such as aluminum, galvanized metal, steel, stainless steel) that is durable, water-resistant, and of sufficient rigidity to maintain its integrity on uneven ground surfaces such that member does not bend or conform to the ground surface during use.

The global Walking Aids market is estimated to grow from USD 2.2 billion in 2018 to USD 3.72 billion by 2026, at a Compound Annual Growth Rate (CAGR) of 6.8% during the forecast period.

Please contact Justin Ehrlickman via email at justin@ipapproach.com or phone at 845-558-7901 to receive a Brokerage Marketing Package.

abstract-3166168__340

“Systems, Devices, and/or Methods for Managing Transdermal Patches”

IPApproach LLC is pleased to present the exclusive patent for sale “Systems, devices, and/or methods for managing transdermal patches” which includes U.S. Granted Patent US 10,661,065 B1 assigned to N Brereton Medical Technologies LLC. The IP relates to a system for manually controlling the delivery of a transdermally-delivered medication. The technology disclosed provides the following  advantages:

    • It maintain the lower dose of medication and further control the delivery flow rate of medication to the skin of patient using flux controller.
    • The transdermal patch offers a continuous, sustained release of drug and avoids daily peak and trough hormone levels.
    • Flux controller consists of impermeable portion containing apertures which allow the medication to permeate from patch to skin.

The Global Transdermal Skin patches market was worth $6.23 billion in 2019. It is expected to grow at a compound annual growth rate (CAGR) of 4.5% till 2023.

Please contact Justin Ehrlickman via email at justin@ipapproach.com or phone at 845-558-7901 to receive a Brokerage Marketing Package.

abstract-3166168__340

“Orthopaedic methods or devices for non-surgical treatment of bones or joints”

IPApproach LLC is pleased to present the attached exclusive patent portfolio for sale listed in slides 6 to 8 which includes 22 U.S. Granted Patents assigned to Nordt Development Co. The IP relates to “Orthopaedic methods or devices for non-surgical treatment of bones or joints”. 

  • US 7062865 B1: The technology disclosed provides the following  advantages:
    • Provides foot comfort particularly for athletes as they continue to push their capabilities toward ever higher objectives, i.e. longer distances, higher jumps, etc.
    • Provides the capture and return of energy generated naturally during the gait cycle.
    • Provide a more comfortable shoe insert or insole, particularly for athletic footwear.
    • The material is also preferably lightweight so as not to add to the athletes lifting burden during strenuous activity.
  • US 7704219 B2: The technology disclosed provides the following  advantages:
    • The invention includes a rotary device for effecting adjustments in the tension of the tensioning line, thereby effecting adjustments to the wrist support.
    • There is no need of hard-shell or rigid beam components.
    • Provides simple hinging contraptions. 
  • US 7618386 B2: The technology disclosed provides the following  advantages:
    • Provides deflection of muscle forces.
    • Provides functional shortening of muscle length.
    • Provides the maintenance of neurovascular channels.
  • US 7615021 B2: The technology disclosed provides the following  advantages:
    • Provides external support in hinge joints of the body.
    • Helps address joint fatigue, pain.
    • Provides the capture and return of energy generated naturally during the gait cycle.
    • Advantages of side struts used include substitution of side struts having different ranges of elasticity and flexing properties for providing the desired degrees of flexibility at the hinge joint combined with degrees of rigidity in the first direction along the opposite sides of the framework.
  • US 7670306 B2: The technology disclosed provides the following  advantages:
    • Provides elastically stretchable framework.
    • Advantages of side struts used include substitution of side struts having different ranges of elasticity and flexing properties for providing the desired degrees of flexibility at the hinge joint combined with degrees of rigidity in the first direction along the opposite sides of the framework.
    • A benefit of  the openings extending from inner to outer surfaces of the framework is that these openings may permit portions of the area of the body that are in abutting engagement with the framework to breathe, especially where the inner surface directly contacts the body and no intermediate member extends there between, such as a liner

Please contact Justin Ehrlickman via email at justin@ipapproach.com or phone at 845-558-7901 to receive a Brokerage Marketing Package.

abstract-3166168__340

“MAGNETIC DEFIBRILLATOR TRAINING PAD”

IPApproach LLC is pleased to present the attached exclusive patents for sale “Magnetic defibrillator training pad” which includes U.S. Granted Patent US 9,373,271 B2 assigned to Cristine Petruzziello. The IP relates to a to defibrillator training system. More Specifically, magnetic defibrillator training pad receivable on a training dummy. The technology disclosed provides the following  advantages:

  • Traditional defibrillator training pads comprise a sticky adhesive that allows them to be placed on the dummy and held in place but it attracts lint, dirt, dust, and other particles which stick to the adhesive, rendering it useless. Therefore, present invention enables the use of magnetic metal on pads which allows the pads to be placed in a proper place on training dummy without falling off.
  • The magnetic attached defibrillator training pads can be re-used repeatedly during training.
  • Magnetic attached defibrillator doesn’t attract lint, dust and uses magnet-magnet metal connection between torso and pad.

Please contact Justin Ehrlickman via email at justin@ipapproach.com or phone at 845-558-7901 to receive a Brokerage Marketing Package.

abstract-3166168__340

“SURGICAL DEVICES FOR IMMOBILIZING SACROILIAL JOINT”

IPApproach LLC is pleased to present the attached exclusive patents for sale “Surgical devices for immobilizing sacroilial joint” which includes U.S. Patents US 10245044 B2, US 9241798 B2 assigned to Doulos Medical. The IP relates to a method of medical devices for treatment of the sacroiliac joint.

 The technology disclosed provides the following advantages:

  • The present invention involves insertion of graft which substantially fuse the patient's ilium and sacrum and further immobilizes the patient's SI joint.
  • Helps to decrease the substantial risks which causes discomfort to the patient.
  • Provides high success rate. 
  • Helps in eliminating and reducing the pain resulting from SI joint problems.
  • Helps to reduce the painful friction between the rubbing portion of bones.

Please contact Justin Ehrlickman via email at justin@ipapproach.com or phone at 845-558-7901 to receive a Brokerage Marketing Package.

abstract-3166168__340